Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Rod Ellis-Pegler"'
2
Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects
Autor: Younju Lee, Rod Ellis-Pegler, Deokyoon Jeong, Donghoon Shin
Publikováno v: Drug Design, Development and Therapy
Donghoon Shin,1 Younju Lee,1 Deokyoon Jeong,1 Rod Ellis-Pegler2 1Samsung Bioepis Co. Ltd, Incheon, Republic of Korea; 2Auckland Clinical Studies, Ltd., Auckland, New Zealand Purpose: The objective of this study was to demonstrate comparable pharmacok
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6508e4c5eaa2e6f918b464d6d9ed10d5
https://pubmed.ncbi.nlm.nih.gov/30464411
Zobrazit plný text záznamu
3
Late-onset bolus intravenous beta-lactam antibiotic adverse reaction: Short-lived symptoms during drug administration and associated laboratory abnormalities
Autor: Stephen Ritchie, Stella Smith, Simon Briggs, Rod Ellis-Pegler, Penny Fitzharris
Publikováno v: Scandinavian Journal of Infectious Diseases. 46:14-20
In the 1970s, there were 2 reports of a late-onset adverse reaction during bolus infusions of benzyl penicillin, characterized by short-lived symptoms, most commonly abdominal pain. The mechanism is not known. We set out to further characterize this
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731408ae4ec013e41e14908e239c73bc
https://doi.org/10.3109/00365548.2013.849815
Zobrazit plný text záznamu
4
Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)
Autor: Ian R. Reid, Rod Ellis-Pegler, Greg D. Gamble, Mark J Bolland, Andrew Grey, Anne Horne, Simon Briggs, Mark G. Thomas
Publikováno v: Clinical Endocrinology. 76:643-648
Summary Objective Most longitudinal studies of bone mineral density (BMD) in HIV-infected cohorts have been of short duration, typically 1–2 years. Some studies, especially of cohorts treated with highly active antiretroviral therapy (HAART), repor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6af1b90c303acb0f6633378ad5b85df0
https://doi.org/10.1111/j.1365-2265.2011.04274.x
Zobrazit plný text záznamu
5
Evolution of Central Nervous System Multidrug-Resistant Mycobacterium tuberculosis and Late Relapse of Cryptic Prosthetic Hip Joint Tuberculosis: Complications during Treatment of Disseminated Isoniazid-Resistant Tuberculosis in an Immunocompromised Host
Autor: Rod Ellis-Pegler, Arlo Upton, Andrew Woodhouse, Ross Vaughan, Sandie Newton
Publikováno v: Journal of Clinical Microbiology. 47:507-510
We report a case of disseminated isoniazid-resistant tuberculosis in an immunocompromised patient with evolution of rifampin (rifampicin) resistance in the central nervous system. This was cured with intraventricular and oral treatment but was follow
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a409af02f827fbe6bb3100045e4ef9a8
https://doi.org/10.1128/jcm.01473-08
Zobrazit plný text záznamu
6
Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients
Autor: Andrew Woodhouse, Priscilla Rupali, Mark G. Thomas, Rod Ellis-Pegler
Publikováno v: Scandinavian Journal of Infectious Diseases. 41:862-868
Pneumocystis jirovecii pneumonia (PCP) in human immunodeficiency virus (HIV)-infected patients is usually treated with trimethoprim (TMP)-sulfamethoxazole (SMX) 1920 mg 3 times daily (approximately equivalent to TMP 15 mg/kg/day-SMX 75 mg/kg/day) for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292124247005d3b7d2ef1d71b7d41e8f
https://doi.org/10.3109/00365540903214256
Zobrazit plný text záznamu
7
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years
Autor: Simon Briggs, Mark G. Thomas, Rod Ellis-Pegler, Greg D. Gamble, Andrew Grey, Ian R. Reid, Mark J Bolland, Anne Horne, Andrew Woodhouse
Publikováno v: Clinical Endocrinology. 67:270-275
Summary Objective Recently we reported that human immunodeficiency virus (HIV)-infected Caucasian men treated with highly active antiretroviral therapy (HAART) have normal weight-adjusted bone mineral density (BMD), in contrast to most other cross-se
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::18d24efcc9f9485a82eedabcdd2f2c87
https://doi.org/10.1111/j.1365-2265.2007.02875.x
Zobrazit plný text záznamu
8
Annual Zoledronate Increases Bone Density in Highly Active Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Men: A Randomized Controlled Trial
Autor: Mark J Bolland, Rod Ellis-Pegler, Greg D. Gamble, Simon Briggs, Mark G. Thomas, Andrew Woodhouse, Ian R. Reid, Anne Horne, Andrew Grey
Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 92:1283-1288
Recent studies have reported low bone mineral density (BMD) in HIV-infected patients. Annual iv administration of 4 mg zoledronate has been shown to increase BMD and suppress bone turnover in postmenopausal women.The objective of the study was to det
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a14f1de9f1dc4dcbe35da1cb547060c8
https://doi.org/10.1210/jc.2006-2216
Zobrazit plný text záznamu
10
Hydrocephalus in herpes simplex type 2 meningitis
Autor: Elaine Yap, Rod Ellis-Pegler
Publikováno v: Journal of Infection. 53:e75-e77
A 34-year-old woman presented to hospital with symptoms of meningitis, later confirmed to be due to herpes simplex virus type 2. She developed hydrocephalus on day 2 of her admission. We describe the first case of hydrocephalus associated with herpes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cff9a7e1588e50cf10628a20f43a5811
https://doi.org/10.1016/j.jinf.2005.10.007
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje